Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.64)
# 3,209
Out of 4,761 analysts
177
Total ratings
37.97%
Success rate
-5.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Downgrades: Underweight | $9 → $4 | $5.73 | -30.19% | 9 | Dec 2, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $591.79 | +9.84% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $2.53 | +97.63% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.10 | -14.89% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $119.44 | +8.84% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $104.83 | +14.47% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $71.95 | +32.04% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $89.94 | +8.96% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $90.31 | -5.88% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $28.26 | -46.92% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $282.80 | +21.29% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $8.96 | +56.25% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $33.82 | +41.93% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $73.30 | +39.15% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $104.49 | -44.49% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.75 | +26.98% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $88.78 | +47.56% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $134.92 | -1.42% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $382.78 | -42.53% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $175.64 | +115.21% | 2 | Feb 25, 2022 |
Nevro
Dec 2, 2024
Downgrades: Underweight
Price Target: $9 → $4
Current: $5.73
Upside: -30.19%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $591.79
Upside: +9.84%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.53
Upside: +97.63%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.10
Upside: -14.89%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $119.44
Upside: +8.84%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $104.83
Upside: +14.47%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $71.95
Upside: +32.04%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $89.94
Upside: +8.96%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $90.31
Upside: -5.88%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $28.26
Upside: -46.92%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $282.80
Upside: +21.29%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $8.96
Upside: +56.25%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $33.82
Upside: +41.93%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $73.30
Upside: +39.15%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $104.49
Upside: -44.49%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.75
Upside: +26.98%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $88.78
Upside: +47.56%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $134.92
Upside: -1.42%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $382.78
Upside: -42.53%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $175.64
Upside: +115.21%